Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher L Cooper

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Frontiers in Immunology|February 2, 2017
BRILIA: Integrated Tool for High-Throughput Annotation and Lineage Tree Assembly of B-Cell RepertoiresDonald W Lee, Ilja V Khavrutskii, Anders Wallqvist, et al.
Molecular Cell|October 7, 2003
Identification of modulators of TRAIL-induced apoptosis via RNAi-based phenotypic screeningPedro Aza-Blanc, Christopher L Cooper, Klaus Wagner, et al.
Research in Developmental Disabilities|August 10, 2010
The use of clozapine among individuals with intellectual disability: a reviewAshvind N Singh, Johnny L Matson, B D Hill, et al.
Vaccine|May 19, 2020
Adjuvant selection impacts the correlates of vaccine protection against Ebola infectionSabrina M Stronsky, Christopher L Cooper, Jesse Steffens, et al.
Emerging Microbes & Infections|June 8, 2017
T-cell-dependent mechanisms promote Ebola VLP-induced antibody responses, but are dispensable for vaccine-mediated protectionChristopher L Cooper, Karen A Martins, Sabrina M Stronsky, et al.
Frontiers in Immunology|September 1, 2017
Quantitative Analysis of Repertoire-Scale Immunoglobulin Properties in Vaccine-Induced B-Cell ResponsesIlja V Khavrutskii, Sidhartha Chaudhury, Sabrina M Stronsky, et al.
ACS Nano|September 10, 2019
Multilamellar Vaccine Particle Elicits Potent Immune Activation with Protein Antigens and Protects Mice against Ebola Virus InfectionYuchen Fan, Sabrina M Stronsky, Yao Xu, et al.
Vaccine|July 23, 2025
The natural history of infection with Sudan virus compared to Ebola virus in non-human primates: a rapid reviewHilary S Whitworth, Thomas S Postler, Christopher L Cooper, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 25, 2018
Vaccine nanoparticles displaying recombinant Ebola virus glycoprotein for induction of potent antibody and polyfunctional T cell responsesJoseph D Bazzill, Sabrina M Stronsky, Laura C Kalinyak, et al.
Ebiomedicine|April 1, 2025
Mapping the antibody response to Lassa virus vaccination of non-human primatesAdrian S Enriquez, Ruben Diaz Avalos, Diptiben Parekh, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Frontiers in Immunology|February 2, 2017
BRILIA: Integrated Tool for High-Throughput Annotation and Lineage Tree Assembly of B-Cell RepertoiresDonald W Lee, Ilja V Khavrutskii, Anders Wallqvist, et al.
Molecular Cell|October 7, 2003
Identification of modulators of TRAIL-induced apoptosis via RNAi-based phenotypic screeningPedro Aza-Blanc, Christopher L Cooper, Klaus Wagner, et al.
Research in Developmental Disabilities|August 10, 2010
The use of clozapine among individuals with intellectual disability: a reviewAshvind N Singh, Johnny L Matson, B D Hill, et al.
Vaccine|May 19, 2020
Adjuvant selection impacts the correlates of vaccine protection against Ebola infectionSabrina M Stronsky, Christopher L Cooper, Jesse Steffens, et al.
Emerging Microbes & Infections|June 8, 2017
T-cell-dependent mechanisms promote Ebola VLP-induced antibody responses, but are dispensable for vaccine-mediated protectionChristopher L Cooper, Karen A Martins, Sabrina M Stronsky, et al.
Frontiers in Immunology|September 1, 2017
Quantitative Analysis of Repertoire-Scale Immunoglobulin Properties in Vaccine-Induced B-Cell ResponsesIlja V Khavrutskii, Sidhartha Chaudhury, Sabrina M Stronsky, et al.
ACS Nano|September 10, 2019
Multilamellar Vaccine Particle Elicits Potent Immune Activation with Protein Antigens and Protects Mice against Ebola Virus InfectionYuchen Fan, Sabrina M Stronsky, Yao Xu, et al.
Vaccine|July 23, 2025
The natural history of infection with Sudan virus compared to Ebola virus in non-human primates: a rapid reviewHilary S Whitworth, Thomas S Postler, Christopher L Cooper, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 25, 2018
Vaccine nanoparticles displaying recombinant Ebola virus glycoprotein for induction of potent antibody and polyfunctional T cell responsesJoseph D Bazzill, Sabrina M Stronsky, Laura C Kalinyak, et al.
Ebiomedicine|April 1, 2025
Mapping the antibody response to Lassa virus vaccination of non-human primatesAdrian S Enriquez, Ruben Diaz Avalos, Diptiben Parekh, et al.
Pageof 4